548 Epizód

  1. Accelerating the Development of Genetic Medicines with AI

    Közzétéve: 2023. 12. 07.
  2. Leveraging AI to Address the Neuropsychiatric Conditions Associated with a Rare Disease

    Közzétéve: 2023. 11. 30.
  3. In Pursuit of a Treatment for His Son, A Lawyer Becomes a Biotech Executive

    Közzétéve: 2023. 11. 22.
  4. In Push for Treatment, a Patient Organization Becomes a Trial Sponsor

    Közzétéve: 2023. 11. 16.
  5. Delayed Diagnosis of Rare Diseases Takes Staggering Economic Toll

    Közzétéve: 2023. 11. 09.
  6. A Cell Therapy to Control Heart-Damaging Inflammation in Duchenne

    Közzétéve: 2023. 11. 02.
  7. Stimulating the Growth of Muscle Mass in People with Neuromuscular Diseases

    Közzétéve: 2023. 10. 26.
  8. Turning Grief into Action

    Közzétéve: 2023. 10. 19.
  9. A Plea to the FDA to Give an Ultra-Rare Disease Drug a Fair Hearing

    Közzétéve: 2023. 10. 12.
  10. How the Woolly Mammoth Beat a Path to Better Gene Therapies

    Közzétéve: 2023. 10. 05.
  11. A Genetic Counselor’s Journey into Patient Advocacy

    Közzétéve: 2023. 09. 28.
  12. A Company in the Fold of Rare Disease

    Közzétéve: 2023. 09. 21.
  13. Disabling Antibodies that Drive Rare, Immunological Conditions

    Közzétéve: 2023. 09. 14.
  14. Keeping the Sentinels of the Brain Vigilant

    Közzétéve: 2023. 09. 07.
  15. Considering the Unfinished Work in Cystic Fibrosis

    Közzétéve: 2023. 08. 31.
  16. How to Advocate for Yourself as You Battle Cancer

    Közzétéve: 2023. 08. 24.
  17. Targeting Neuroinflammation to Treat ALS

    Közzétéve: 2023. 08. 17.
  18. Leveraging Community Partnerships to Address a Rare Disease Behind a Medical Mystery in New Mexico

    Közzétéve: 2023. 08. 10.
  19. Accelerating Gene Editing Therapies for Rare, Neurological Conditions

    Közzétéve: 2023. 08. 03.
  20. Inhibiting Electrical Activity in Rare, Seizure Disorders

    Közzétéve: 2023. 07. 27.

5 / 28

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Visit the podcast's native language site